Kazia Therapeutics logo

Kazia Therapeutics

KZIA | NASDAQ
Chart Builder DCF Calculator
$5.60
-$1.02 (-15.41%)
At close: Nov 16, 2026, 4:00 PM ET
$5.60
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:46 PM ET
-15.41%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
45
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #390/1021 (Top 38%)

Key Statistics

Market Data

Market Cap $17.47M
1D Range
5.43 6.69
52W Range
5.00 16.90

Valuation (TTM)

PE -0.84
PB 0.56
EV/EBITDA 2.37

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $32.00
Loading financial charts...

Profile

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, br...

Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date Jan 6, 1999
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$32.00
Upside
+471.43%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.